Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.

Current limitations in nucleic acid amplification testing (NAAT) for SARS-CoV-2 in low-resource settings highlight the need for alternative diagnostic tools. While point-of-care serological tests are available, their reliability remains poorly documented. Prior research has shown that serological tests can detect antibodies after infection, but their accuracy in asymptomatic populations is unclear. This gap motivated the study to evaluate two serological test kits in Nigeria. No prior work had resolved the comparative performance of ELISA and RDT in this context. The study aimed to address this uncertainty by analyzing sensitivity and specificity in a real-world setting. Existing studies have not fully explored the diagnostic value of these tests in asymptomatic individuals. This research fills that knowledge gap by examining test performance against PCR results. The findings may help guide diagnostic strategy in resource-limited areas.

This study aimed to evaluate the performance of two serological test kits for SARS-CoV-2 detection in a Nigerian population. The specific problem addressed was the lack of documented reliability for point-of-care tests in low-resource settings. The motivation came from the need to support diagnostic efforts in areas where NAATs are not widely accessible. Researchers focused on comparing ELISA and RDT against PCR as a gold standard. The study sought to determine which test offers better sensitivity or specificity. It also aimed to calculate predictive values and likelihood ratios for diagnostic accuracy. The goal was to inform public health decisions on test deployment. The findings could help optimize serological screening strategies.

The study enrolled 47 asymptomatic adults who had previously undergone RT-PCR testing for SARS-CoV-2. Blood samples were collected for antibody detection using ELISA and RDT. The tests focused on IgM and IgG antibodies specific to the SARS-CoV-2 S-antigen. Researchers used Fisher's Exact test to assess associations between test results and PCR outcomes. Sensitivity and specificity were calculated using ROC analysis. Additional metrics included PPV, NPV, PLR, NLR, DOR, and overall accuracy. The study compared the performance of ELISA and RDT in detecting IgM and IgG antibodies. Statistical analysis was conducted to evaluate diagnostic reliability and agreement with PCR results.

Of the 47 participants, 28 (59.6%) had positive PCR results. ELISA identified 20 (42.6%) as antibody-positive, while RDT detected 13 (27.7%). ELISA showed higher sensitivity, NPV, PLR, DOR, and accuracy than RDT. RDT had better specificity than ELISA. The proportion of IgM-positive cases was higher with ELISA than RDT. Conversely, IgG-positive cases were higher with RDT than ELISA. ELISA demonstrated superior sensitivity in detecting SARS-CoV-2 Spike-protein antibodies. The combination of ELISA and RDT may improve screening accuracy in populations.

The study found that ELISA outperformed RDT in sensitivity and several diagnostic metrics. RDT showed better specificity but lower overall detection rates. The authors suggest that ELISA may be more suitable for detecting recent infections due to higher IgM detection. RDT may be better for confirming past exposure due to higher IgG detection. The combination of both tests could enhance screening effectiveness in populations. These findings align with the study's aim to inform diagnostic strategy in Nigeria. The authors propose that ELISA is preferable for initial screening in low-resource settings. The results support the use of combined testing for more comprehensive serological surveillance.